Valuation: Virbac

Market Cap 286.94Cr 326.66Cr 264.37Cr 247.19Cr 463.62Cr 31TCr 472.13Cr 3.17TCr 1.23TCr 15TCr 1.23TCr 1.2TCr 53TCr P/E 2026 *
17.1x
P/E 2027 * 15.2x
Enterprise Value 299.04Cr 340.44Cr 275.52Cr 257.62Cr 483.17Cr 32TCr 492.03Cr 3.31TCr 1.28TCr 16TCr 1.28TCr 1.25TCr 55TCr EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.77x
Free-Float
49.03%
Yield 2026 *
0.51%
Yield 2027 * 0.6%
1 day+1.20%
1 week+2.11%
Current month-5.98%
1 month-4.79%
3 months-2.31%
6 months-3.01%
Current year-3.01%
1 week 323
Extreme 323
338.5
1 month 323
Extreme 323
362.5
Current year 322
Extreme 322
381
1 year 297
Extreme 297
381
3 years 237.5
Extreme 237.5
392
5 years 220.5
Extreme 220.5
440.5
10 years 102.48
Extreme 102.479
440.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+2.11% - - 324.02Cr
-0.45%-1.13%-50.51%-53.78% 3.28TCr
+1.71%+0.62%+77.11%+148.17% 1.2TCr
-2.48%-7.94%-5.44%+16.05% 419.47Cr
-1.71%+1.51%+50.44%+30.45% 197.32Cr
+0.50%-1.47%-28.01%+0.37% 162.7Cr
+1.50%-0.06%+28.61%+136.30% 127.21Cr
-1.85%-3.14%-23.84%-16.55% 100.74Cr
-0.28%+4.66%-0.69%-18.57% 95Cr
-2.59%-6.38%-17.31%-48.63% 93Cr
Average -0.44%-0.27%+3.37%+21.53% 629.9Cr
Weighted average by Cap. -0.10%+0.81%-12.45%+4.10%

Financials

2026 *2027 *
Net sales 154.64Cr 176.04Cr 142.47Cr 133.22Cr 249.85Cr 17TCr 254.44Cr 1.71TCr 662.12Cr 8.19TCr 661.1Cr 646.61Cr 28TCr 163.95Cr 186.65Cr 151.06Cr 141.24Cr 264.9Cr 18TCr 269.76Cr 1.81TCr 702Cr 8.68TCr 700.91Cr 685.55Cr 30TCr
Net income 17Cr 19Cr 15Cr 14Cr 27Cr 1.79TCr 27Cr 184.64Cr 72Cr 884.47Cr 71Cr 70Cr 3.07TCr 19Cr 22Cr 18Cr 16Cr 31Cr 2.04TCr 31Cr 210.26Cr 81Cr 1.01TCr 81Cr 80Cr 3.5TCr
Net Debt 12Cr 14Cr 11Cr 10Cr 20Cr 1.3TCr 20Cr 133.75Cr 52Cr 640.7Cr 52Cr 51Cr 2.23TCr 2.65Cr 3.02Cr 2.44Cr 2.28Cr 4.28Cr 284.59Cr 4.36Cr 29Cr 11Cr 140.29Cr 11Cr 11Cr 487.52Cr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change
25/26/25 €338.00 +1.20%
24/26/24 €334.00 +0.60%
23/26/23 €332.00 -0.30%
22/26/22 €333.00 +0.45%
19/26/19 €331.50 +1.69%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
342.50EUR
Average target price
412.88EUR
Spread / Average Target
+20.55%

Quarterly revenue - Rate of surprise